BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $385K invested in ProShares UltraShort NASDAQ Biotechnology in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$289K
2
+$1K

Top Sellers

1
-$443K
2
-$187K
3
-$119K
4
Morgan Stanley
Morgan Stanley
New York
-$1.47K
5
UBS Group
UBS Group
Switzerland
-$221
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$289K
2
$92.6K
3
$1.42K
4
$1.25K
5
$1K
6
$17
7
–
8
–